- Home
- ACTG vs NGNE Comparison
ACTG vs NGNE Comparison
Compare ACTG & NGNE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACTG
- NGNE
- Stock Information
- Founded
- ACTG 1993
- NGNE 2003
- Country
- ACTG United States
- NGNE United States
- Employees
- ACTG N/A
- NGNE N/A
- Industry
- ACTG Multi-Sector Companies
- NGNE Biotechnology: Pharmaceutical Preparations
- Sector
- ACTG Miscellaneous
- NGNE Health Care
- Exchange
- ACTG Nasdaq
- NGNE Nasdaq
- Market Cap
- ACTG 453.7M
- NGNE 471.1M
- IPO Year
- ACTG 1996
- NGNE N/A
- Fundamental
- Price
- ACTG $4.53
- NGNE $15.59
- Analyst Decision
- ACTG Strong Buy
- NGNE Strong Buy
- Analyst Count
- ACTG 1
- NGNE 6
- Target Price
- ACTG $7.00
- NGNE $60.80
- AVG Volume (30 Days)
- ACTG 331.4K
- NGNE 539.5K
- Earning Date
- ACTG 11-12-2024
- NGNE 11-18-2024
- Dividend Yield
- ACTG N/A
- NGNE N/A
- EPS Growth
- ACTG N/A
- NGNE N/A
- EPS
- ACTG 0.39
- NGNE N/A
- Revenue
- ACTG $165,779,000.00
- NGNE $925,000.00
- Revenue This Year
- ACTG N/A
- NGNE N/A
- Revenue Next Year
- ACTG $21.60
- NGNE N/A
- P/E Ratio
- ACTG $11.62
- NGNE N/A
- Revenue Growth
- ACTG 261.08
- NGNE N/A
- 52 Week Low
- ACTG $3.58
- NGNE $12.49
- 52 Week High
- ACTG $5.74
- NGNE $74.49
- Technical
- Relative Strength Index (RSI)
- ACTG 49.07
- NGNE 26.51
- Support Level
- ACTG $4.40
- NGNE $35.60
- Resistance Level
- ACTG $4.56
- NGNE $43.24
- Average True Range (ATR)
- ACTG 0.15
- NGNE 6.30
- MACD
- ACTG -0.00
- NGNE -5.15
- Stochastic Oscillator
- ACTG 60.00
- NGNE 1.85
About ACTG Acacia Research Corporation (Acacia Tech)
Acacia Research Corp is focused on acquiring and operating businesses across the industrial, energy, and technology sectors where it believes it can leverage its expertise, significant capital base, and deep industry relationships to drive value. Acacia evaluates opportunities based on the attractiveness of the underlying cash flows, without regard to a specific investment horizon. Acacia operates its businesses based on three key principles of people, process, and performance and has built a management team with demonstrated expertise in research, transactions and execution, and operations and management.
About NGNE Neurogene Inc.
Neurogene Inc is a clinical stage biotechnology company whose objective is to harness the power of gene therapy which is combined with its EXACT gene regulation technology to turn today's complex devastating neurological diseases into treatable conditions.